BP8 logo

BPH Global Ltd Stock Price

ASX:BP8 Community·AU$2.8m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BP8 Share Price Performance

AU$0
-0.00 (-100.00%)
AU$0
-0.00 (-100.00%)
Price AU$0

BP8 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Moderate risk with mediocre balance sheet.

5 Risks
1 Reward

BPH Global Ltd Key Details

AU$352.4k

Revenue

AU$328.2k

Cost of Revenue

AU$24.2k

Gross Profit

AU$1.5m

Other Expenses

-AU$1.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.0008
6.86%
-421.87%
0%
View Full Analysis

About BP8

Founded
1984
Employees
n/a
CEO
Matthew Leonard
WebsiteView website
www.scu.com.sg

BPH Global Ltd, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia. The company’s products include raw bird’s nest and processed bird’s nest products, and Caulerpa Lentillifera, sea grapes and seaweeds. Its products are used in the food, nutrition, healthcare, health supplements, cosmetics and personal care industries. BPH Global Ltd was formerly known as Stemcell United Limited and changed its name to BPH Global Ltd in June 2023. The company was incorporated in 1984 and is headquartered in Melbourne, Australia.

Recent BP8 News & Updates

Recent updates

No updates